10 Best Long-Term Stocks to Invest In According to Bill & Melinda Gates Foundation Trust
Expect stocks to rise into year-end, despite the ongoing rotation from all-time highs.
Schrodinger Inc. (SDGR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bill & Melinda Gates Foundation Trust Michael Larson | 6,981,664 | $79,311,703 | 0.25% | |
| 2. | Rubric Capital Management David Rosen | 6,000,000 | $68,160,000 | +44% | 0.72% |
| 3. | ARK Investment Management Catherine D. Wood | 2,067,135 | $23,482,650 | -3% | 0.18% |
| 4. | GLG Partners Noam Gottesman | 681,103 | $7,737,330 | +55% | 0.01% |
| 5. | Tudor Investment Corp Paul Tudor Jones | 550,540 | $6,254,134 | +26% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.90 | 1,115 | $111,385.94 | 0 | 2021-02-05 | Filing | |
| $17.00 | 588,235 | $9,999,995.00 | 6,981,664 | 2020-02-10 | Filing | |
| $17.00 | 250,000 | $4,250,000.00 | 250,000 | 2020-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.21 | 43,000 | $524,944.00 | 330,824 | 2026-04-17 | Filing | |
| $12.33 | 43,000 | $530,233.00 | 330,824 | 2026-04-16 | Filing | |
| $12.75 | 844 | $10,758.47 | 51,752 | 2026-04-16 | Filing | |
| $12.84 | 608 | $7,807.94 | 34,804 | 2026-03-06 | Filing | |
| $12.85 | 775 | $9,955.65 | 35,412 | 2026-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,678,560 | $109,948,440 | 0% | |
| 2. | 3,862,197 | $43,874,558 | 0% | |
| 3. | 3,190,837 | $36,247,908 | 0.51% | |
| 4. | 3,190,837 | $36,247,908 | 0.02% | |
| 5. | 2,684,692 | $30,498,101 | 0.01% |
News See All
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2026 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrödinger, Inc.'s conference call to review first quarter 2026 financial results. My name is Rob, and I will be your operator for today's call.
10 Best All-Time Low Stocks to Buy in 2026
On April 28, Tom Lee of Fundstrat appeared on CNBC to discuss the market outlook for 2026. Lee highlighted that the market faced three major potential challenges at the start of 2026.
10 Best Medical AI Stocks to Buy Now
Artificial intelligence has driven significant gains in the equity market over the past two years.
Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth
Schrodinger Inc. (NASDAQ:SDGR) is one of the best cancer stocks to invest in now. On February 25, Schrodinger Inc.
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
Schrödinger, Inc. (NASDAQ:SDGR) Q4 2025 Earnings Call Transcript
Operator: Thank you standing by. Welcome to Schrodinger's conference call to review fourth quarter and full year 2025 financial results. My name is Rob, and I'll be your operator for today's call.
BofA Upgrades Schrödinger (SDGR) to Buy After Strategic Pivot to Software
Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded Schrödinger, Inc.
11 Best Healthcare AI Stocks to Buy Now
On August 13, 2025, the World Economic Forum (WEF) published an analysis exploring how AI is transforming healthcare.
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrodinger's conference call to review third quarter 2025 financial results. My name is Rob, and I'll be your operator for today's call.
Hedge Fund Resource Center